Influence of peak inspiratory flow rates and pressure drops on inhalation performance of dry powder inhalers

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 3, 2012, Pages 341-347

  Hira, Daiki ^a   Okuda, Tomoyuki ^a   Ichihashi, Mika ^a   Mizutani, Ayano ^a   Ishizeki, Kazunori ^b   Okada, Toyoko ^b   Okamoto, Hirokazu ^a  

^a MEIJO UNIVERSITY   (Japan)

^b Hitachi Automotive Systems Ltd   (Japan)

Author keywords

Dry powder inhaler; Human inspiratory flow simulator; Inhalation device; Inspiratory flow rate; Powder formulation

Indexed keywords

LACTOSE; SALBUTAMOL SULFATE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FLOW RATE; HUMAN; IN VITRO STUDY; INHALATION TEST; MALE; PEAK INSPIRATORY FLOW; PERFORMANCE MEASUREMENT SYSTEM; POWDER INHALER;

ADMINISTRATION, INHALATION; ADULT; ALBUTEROL; BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; DRY POWDER INHALERS; FEMALE; HUMANS; INHALATION; LACTOSE; MALE; PARTICLE SIZE; POWDERS; PRESSURE; YOUNG ADULT;

EID: 84857840702     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.60.341     Document Type: Article

References (26)

1. Dalby R., Suman J., Adv. Drug Deliv. Rev., 55, 779-791 (2003).
2. Pilcer G., Amighi K., Int. J. Pharm., 392, 1-19 (2010).
3. Sumby B., Slater A., Atkins P. J., Prime D., Adv. Drug Deliv. Rev., 26, 51-58 (1997).
4. Newman S. P., Busse W. W., Respir. Med., 96, 293-304 (2002).
5. Atkins P. J., Respir. Care, 50, 1304-1312, discussion, 1312 (2005).
6. Pilcer G., Wauthoz N., Amighi K., Adv. Drug Deliv. Rev., doi:10.1016/j.addr.2011.05.003 (2011).
7. de Boer A. H., Chan H. K., Price R., Adv. Drug Deliv. Rev., doi:10.1016/j.addr.2011.04.004 (2011).
8. Coates M. S., Chan H. K., Fletcher D. F., Chiou H., Pharm. Res., 24, 1450-1456 (2007).
9. Coates M. S., Fletcher D. F., Chan H. K., Raper J. A., Pharm. Res., 22, 923-932 (2005).
10. Islam N., Gladki E., Int. J. Pharm., 360, 1-11 (2008).
11. de Boer A. H., Gjaltema D., Hagedoorn P., Int. J. Pharm., 138, 45-56 (1996).
12. Chavan V., Dalby R., AAPS PharmSci, 2, E10 (2000).
13. Borgström L., Bisgaard H., Callaghan C. O., Pedersen S., "Drug Delivery to the Lung," Vol. 162, Chap. 13, ed. by Bisgaard H., Callaghan C. O., Smaldone G. C., 2002, pp. 421-448.
14. Clark A. R., Hollingworth A. M., J. Aerosol Med., 6, 99-110 (1993).
15. Srichana T., Martin G. P., Marriott C., Eur. J. Pharm. Sci., 7, 73-80 (1998).
16. Coates M. S., Fletcher D. F., Chan H. K., Raper J. A., J. Pharm. Sci., 93, 2863-2876 (2004).
17. Coates M. S., Chan H. K., Fletcher D. F., Raper J. A., J. Pharm. Sci., 95, 1382-1392 (2006).
18. Louey M. D., Oort M. V., Hickey A. J., J. Aerosol Sci., 37, 1520-1531 (2006).
19. Xu Z., Mansour H. M., Mulder T., McLean R., Langridge J., Hickey A. J., J. Pharm. Sci., 99, 3398-3414 (2010).
20. Xu Z., Mansour H. M., Mulder T., McLean R., Langridge J., Hickey A. J., J. Pharm. Sci., 99, 3415-3429 (2010).
21. Mansour H. M., Xu Z., Hickey A. J., J. Pharm. Sci., 99, 3430-3441 (2010).
22. Xu Z., Mansour H. M., Mulder T., McLean R., Langridge J., Hickey A. J., J. Pharm. Sci., 99, 3442-3461 (2010).
23. Hira D., Okuda T., Kito D., Ishizeki K., Okada T., Okamoto H., Pharm. Res., 27, 2131-2140 (2010).
24. Iida K., Inagaki Y., Todo H., Okamoto H., Danjo K., Luenberger H., Chem. Pharm. Bull., 52, 938-942 (2004).
25. Kawashima Y., Serigano T., Hino T., Yamamoto H., Takeuchi H., Int. J. Pharm., 172, 179-188 (1998).
26. Coates M. S., Chan H. K., Fletcher D. F., Raper J. A., Pharm. Res., 22, 1445-1453 (2005).